The World Drug Safety Congress Europe will bring together 1500 key through leaders to explore key challenges in pharmacovigilance. From exploring the use of big data and AI in pharmacovigilance, examining benefit-risk management strategies and patient centric approaches, drug safety is at the forefront of innovative technologies that will have an impact on the lives of patients.
Next generation safety solutions that leverage AI and cloud technologies for example, are disruptive technologies that can help create a culture and community of innovation, all while improving patient safety.
This meeting will bridge the gap between international regulatory bodies, industry professionals and patient representatives, bringing key actors and across industries and geographical regions.
Source: Terrapinn